UK Immunotherapy Drugs Market Size & Outlook, 2025-2030
Related Markets
UK immunotherapy drugs market highlights
- The UK immunotherapy drugs market generated a revenue of USD 9,936.2 million in 2024 and is expected to reach USD 18,756.9 million by 2030.
- The UK market is expected to grow at a CAGR of 11.2% from 2025 to 2030.
- In terms of segment, monoclonal antibodies was the largest revenue generating drug type in 2024.
- Vaccine is the most lucrative drug type segment registering the fastest growth during the forecast period.
Immunotherapy drugs market data book summary
| Market revenue in 2024 | USD 9,936.2 million |
| Market revenue in 2030 | USD 18,756.9 million |
| Growth rate | 11.2% (CAGR from 2025 to 2030) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Vaccine |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibodies, Immunomodulator, Vaccine |
Other key industry trends
- In terms of revenue, UK accounted for 3.9% of the global immunotherapy drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany immunotherapy drugs market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 11,738.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunotherapy Drugs Market Scope
Immunotherapy Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson Services, Inc. | View profile | - | - | - |
| Pfizer Inc. | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| AbbVie Inc. | View profile | - | - | - |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
UK immunotherapy drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunotherapy drugs market will help companies and investors design strategic landscapes.
Monoclonal antibodies was the largest segment with a revenue share of 62.29% in 2024. Horizon Databook has segmented the UK immunotherapy drugs market based on monoclonal antibodies, immunomodulator, vaccine covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to UK immunotherapy drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK immunotherapy drugs market databook
-
Our clientele includes a mix of immunotherapy drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK immunotherapy drugs market , including forecasts for subscribers. This country databook contains high-level insights into UK immunotherapy drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK immunotherapy drugs market size, by drug type, 2018-2030 (US$M)
UK Immunotherapy Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
